Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or nontransformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGF beta bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-beta and was not affected by the presence of immunoneutralizing anti-TGF beta antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium.

Medial preoptic/anterior hypothalamic lesions induce a female-typical profile of sexual partner preference in male ferrets.

In T-maze tests given to gonadectomized ferrets treated daily with estradiol benzoate (EB), females consistently prefer to approach and interact sexually with a stud male whereas male subjects, on average, prefer an estrous female. In the present experiment this sexually allomorphic pattern of partner preference was changed in males given lesions of the medial preoptic area/anterior hypothalamus (mPOA/AH). Electrolytic lesions, which caused extensive bilateral damage to the mPOA/AH, including the sexually dimorphic male nucleus (MN) of the POA/AH, led males to shift their mean preference away from the estrous female to the stud male. Their postoperative profile of partner preference more closely resembled that of sham-operated females than that of sham-operated males or of males which sustained either partial or minimal bilateral damage to the mPOA/AH so as to spare the MN-POA/AH in one or both hemispheres. Males with extensive bilateral mPOA/AH lesions, like sham-operated females, showed an even stronger preference to approach the stud male during T-maze tests in which the subjects could smell, see, and hear the stimulus animals without physically interacting with them. After receiving testosterone propionate, male ferrets with either extensive or partial lesions of the mPOA/AH showed significant deficits in neck gripping and mounting performance in tests with either female or male stimulus animals which were sexually receptive after gonadectomy and EB treatment. The present results, coupled with those of a previous study using excitotoxic mPOA/AH lesions, suggest that the male-typical profile of preference for an estrous female depends on the functional integrity of sexually dimorphic mPOA/AH neurons and the reward engendered by coital interaction with such a female. When these neurons either are destroyed experimentally (as in male ferrets with extensive bilateral mPOA/AH lesions) or are absent (as in sham-operated females), subjects are attracted by distal (possibly chemosensory) incentive cues from a stud male.

Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.

BACKGROUND & AIMS: Goblet cells secrete a combination of trefoil peptides and mucin glycoproteins to form a continuous gel on the mucosal surface. The functional effects of these products remain uncertain. METHODS: Trefoil peptides and/or mucin glycoproteins were added to Transwell monolayers of the human colonic cancer-derived T84 cell line. Intact monolayers permitted penetration of < 4% of the inert marker [3H]mannitol at 4 hours. Exposure to the toxic lectin phytohemagglutinin (1 mg/mL), oleic acid (8 mmol/L) and taurocholic acid (12 mmol/L), or Clostridium difficile toxin A (0.7 microgram/mL) resulted in loss of barrier function with 36%, 62%, and 45% of [3H]mannitol penetration, respectively. RESULTS: Addition of recombinant human intestinal trefoil factor in physiological concentrations (1-5 micrograms/microL) resulted in attenuation of the damage to monolayer integrity by up to 52%. Protection was enhanced (up to 95%) by the copresence of human colonic mucin glycoproteins. Similar effects were observed when rat intestinal trefoil factor or human spasmolysin, another human trefoil peptide, were added alone or in the presence of human mucin glycoproteins. Conversely, mucin glycoproteins isolated from the rat colon or stomach facilitated protection when added with human spasmolysin or human intestinal trefoil factor. CONCLUSIONS: Trefoil peptides and mucin glycoproteins protect gastrointestinal mucosa from a variety of insults.